tiprankstipranks
Evoke Pharma (EVOK)
NASDAQ:EVOK
US Market

Evoke Pharma (EVOK) Technical Analysis

Compare
466 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Evoke Pharma’s (EVOK) Moving Averages Convergence Divergence (MACD) indicator is -0.46, suggesting Evoke Pharma is a Buy.
Evoke Pharma’s (EVOK) 20-Day exponential moving average is 3.39, while Evoke Pharma’s (EVOK) share price is $2.79, making it a Sell.
Evoke Pharma’s (EVOK) 50-Day exponential moving average is 3.98, while Evoke Pharma’s (EVOK) share price is $2.79, making it a Sell.

Evoke Pharma (EVOK) Pivot Points

Apr 01, 2025, 03:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.40
2.53
2.66
2.79
2.92
3.05
3.18
Fibonacci
2.53
2.63
2.69
2.79
2.89
2.95
3.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evoke Pharma (EVOK) Moving Averages

Apr 01, 2025, 03:04 AM
Period
Simple
Exponential
MA5
2.82Sell
2.85Sell
MA10
2.97Sell
3.02Sell
MA20
3.40Sell
3.39Sell
MA50
4.24Sell
3.98Sell
MA100
4.46Sell
4.37Sell
MA200
4.96Sell
4.89Sell
Evoke Pharma’s (EVOK) 10-Day exponential moving average is 3.02, while Evoke Pharma’s (EVOK) share price is $2.79, making it a Sell.
Evoke Pharma’s (EVOK) 100-Day exponential moving average is 4.37, while Evoke Pharma’s (EVOK) share price is $2.79, making it a Sell.
Evoke Pharma’s (EVOK) stock price is $2.79 and Evoke Pharma’s (EVOK) 50-day simple moving average is 4.24, creating a Sell signal.
Evoke Pharma’s (EVOK) stock price is $2.79 and Evoke Pharma’s (EVOK) 100-day simple moving average is 4.46, creating a Sell signal.
Evoke Pharma’s (EVOK) stock price is $2.79 and Evoke Pharma’s (EVOK) 200-day simple moving average is 4.96, creating a Sell signal.

Evoke Pharma (EVOK) Technical Indicators

Apr 01, 2025, 03:04 AM
Name
Value
Implied Action
RSI (14)
26.13
Buy
STOCH (9,6)
25.97
Neutral
STOCHRSI (14)
21.47
Neutral
MACD (12,26)
-0.46
Buy
ADX (14)
39.74
Neutral
Williams %R
-80.14
Buy
CCI (14)
-100.62
Buy
ATR (14)
0.35
-
Ultimate Oscillator
42.15
Neutral
ROC
-25.80
Sell
Evoke Pharma’s (EVOK) Relative Strength Index (RSI) is 26.13, creating a Buy signal.
Evoke Pharma’s (EVOK) Trend Strength Indicator (ADX) is 39.74, creating a Neutral signal.
Evoke Pharma’s (EVOK) Commodity Channel Index (CCI) is -100.62, creating a Buy signal.
Evoke Pharma’s (EVOK) Price Rate of Change (ROC) is -25.80, creating a Sell signal.

FAQ

Is EVOK a Buy, Hold, or Sell?
Based on EVOK’s technical indicators, EVOK is a Sell.
    What is EVOK’s RSI (14)?
    EVOK’s RSI (14) is 26.13, which suggests EVOK is a Buy.
      What is EVOK’s MACD?
      EVOK’s MACD is -0.46, which suggests EVOK is a Buy.
        What is EVOK’s 5-day moving average?
        EVOK’s 5-day moving average is 2.82, which suggests EVOK is a Sell.
          What is EVOK’s 20-day moving average?
          EVOK 20-day moving average is 3.40, which suggests EVOK is a Sell.
            What is EVOK’s 50-day moving average?
            EVOK’s 50-day moving average is 4.24, which suggests EVOK is a Sell.
              What is EVOK’s 200-day moving average?
              EVOK’s 200-day moving average is 4.96, which suggests EVOK is a Sell.
                What is EVOK’s Williams % R (14)?
                EVOK’s Williams % R (14) is -80.14, which suggests EVOK is a Buy.
                  What is EVOK’s CCI (14)?
                  EVOK’s CCI (14) is -100.62, which suggests EVOK is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis